CSI Market
Sign In | Register

Cardiol Therapeutics inc (CRDL) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CRDL Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Cardiol Therapeutics inc adapts its asset base and funding mix.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents16.41
Cash & Short-term Investments16.00
Accounts receivable0.04
Other Current Assets1.55
Total Current Assets18.00
Equipment/Property/Plant Net0.09
Intangible AssetsAnd Goodwill0.00
Total Assets18.09
Liabilities
Other Liabilities, Current4.33
Total Current Liabilities4.33
Total Long-term Debt0.00
Other liabilities, Noncurrent0.07
Total Liabilities4.40
Stockholders' Equity
Other Equity13.69
Common Stockholder's Equity13.69
Total Stockholder's Equity13.69
Liabilities & Stockholder's Equity18.09
4 historic quarters locked

Sign in to unlock the full Cardiol Therapeutics inc balance sheet history.

Sign In Create Free Account

About Cardiol Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 40-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-037844

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.